Labeling of neuronal differentiation and neuron cells with biocompatible fluorescent nanodiamonds

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Hsu, Tzu Chia ^a   Liu, Kuang Kai ^a   Chang, Huan Cheng ^b   Hwang, Eric ^a   Chao, Jui I ^a  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^b INSTITUTE OF ATOMIC AND MOLECULAR SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BIOMATERIAL; CD15 ANTIGEN; NANODIAMOND; RETINOIC ACID; TUBULIN;

ANIMAL; APOPTOSIS; ARTICLE; C3H MOUSE; CELL DIFFERENTIATION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; FLUORESCENCE; HUMAN; METABOLISM; MOUSE; NERVE CELL; PHYSIOLOGY; PLURIPOTENT STEM CELL;

ANIMALS; ANTIGENS, CD15; APOPTOSIS; BIOCOMPATIBLE MATERIALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL SURVIVAL; FLUORESCENCE; HUMANS; MICE; MICE, INBRED C3H; NANODIAMONDS; NEURONS; PLURIPOTENT STEM CELLS; TRETINOIN; TUBULIN;

EID: 84901020176     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05004     Document Type: Article

References (49)

1. Brignier, A. C. & Gewirtz, A. M. Embryonic and adult stem cell therapy. J Allergy Clin Immunol 125, S336-S344 (2010).
2. Ding, S. & Schultz, P. G. A role for chemistry in stem cell biology. Nature Biotechnol 22, 833-840 (2004). (Pubitemid 38886601)
3. Evans, M. J. & Kaufman, M. H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-156 (1981). (Pubitemid 11050741)
4. Martin, G. R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 78, 7634-7638 (1981). (Pubitemid 12186197)
5. Matin, M. M. et al. Specific knockdown of Oct4 and beta 2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells. Stem Cells 22, 659-668 (2004). (Pubitemid 39166924)
6. Boyer, L. A. et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122, 947-956 (2005). (Pubitemid 41345211)
7. Greber, B., Lehrach, H. & Adjaye, J. Silencing of core transcription factors in human EC cells highlights the importance of autocrine FGF signaling for selfrenewal. BMC Dev Biol 7 (2007).
8. Andrews, P. W. et al. Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: Opposite sides of the same coin. Biochem Soc Trans 33, 1526-1530 (2005). (Pubitemid 41779730)
9. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006). (Pubitemid 44233629)
10. Park, I.-H., Lerou, P. H., Zhao, R., Huo, H. & Daley, G. Q. Generation of humaninduced pluripotent stem cells. Nature Protoc 3, 1180-1186 (2008).
11. Solter, D. & Knowles, B. B. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci U S A 75, 5565-5569 (1978). (Pubitemid 9084529)
12. Andrews, P. W. et al. Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumours. Int J Cancer 66, 806-816 (1996). (Pubitemid 26197951)
13. Przyborski, S. A., Christie, V. B., Hayman, M. W., Stewart, R. & Horrocks, G. M. Human embryonal carcinoma stem cells: models of embryonic development in humans. Stem Cells Dev 13, 400-8 (2004). (Pubitemid 39223291)
14. McBurney, M. W., Jonesvilleneuve, E. M. V., Edwards, M. K. S. & Anderson, P. J. Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line. Nature 299, 165-167 (1982). (Pubitemid 12056794)
15. Soprano, D. R., Teets, B. W. & Soprano, K. J. Role of retinoic acid in the differentiation of embryonal carcinoma and embryonic stem cells. in Vitamin A, Vol. 75 (ed. Litwack, G) 69-95 (2007).
16. van der Heyden, M. A. G. &Defize, L. H. K. Twenty one years of P19 cells: what an embryonal carcinoma cell line taught us about cardiomyocyte differentiation. Cardiovasc Res 58, 292-302 (2003). (Pubitemid 36570388)
17. Kim, J. H. et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418, 50-56 (2002).
18. Lindvall, O. & Kokaia, Z. Stem cells for the treatment of neurological disorders. Nature 441, 1094-1096 (2006). (Pubitemid 43990722)
19. Glat, M. J. & Offen, D. Cell and Gene Therapy in Alzheimer's Disease. Stem Cells Dev 22, 1490-1496 (2013).
20. Behrstock, S. et al. Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates. Gene Ther 13, 379-388 (2006).
21. Dauer, W. & Przedborski, S. Parkinson's disease: Mechanisms and models. Neuron 39, 889-909 (2003). (Pubitemid 37130207)
22. Wang, F. et al. GDNF-pretreatment enhances the survival of neural stem cells following transplantation in a rat model of Parkinson's disease. Neurosci Res 71, 92-98 (2011).
23. Mochalin, V. N., Shenderova, O., Ho, D. & Gogotsi, Y. The properties and applications of nanodiamonds. Nat Nanotechnol 7, 11-23 (2012).
24. Yu, S. J., Kang, M. W., Chang, H. C., Chen, K. M. & Yu, Y. C. Bright fluorescent nanodiamonds: no photobleaching and low cytotoxicity. J Am Chem Soc 127, 17604-5 (2005).
25. Chang, Y. R. et al. Mass production and dynamic imaging of fluorescent nanodiamonds. Nat Nanotechnol 3, 284-8 (2008).
26. Chao, J. I. et al. Nanometer-sized diamond particle as a probe for biolabeling. Biophys J 93, 2199-208 (2007).
27. Chang, I. P., Hwang, K. C. & Chiang, C. S. Preparation of fluorescent magnetic nanodiamonds and cellular imaging. J Am Chem Soc 130, 15476-81 (2008).
28. Liu, K. K. et al. Alpha-bungarotoxin binding to target cell in a developing visual system by carboxylated nanodiamond. Nanotechnology 19, 205102 (2008).
29. Liu, K. K. et al. Covalent linkage of nanodiamond-paclitaxel for drug delivery and cancer therapy. Nanotechnology 21, 315106 (2010).
30. Edgington, R. J. et al. Patterned neuronal networks using nanodiamonds and the effect of varying nanodiamond properties on neuronal adhesion and outgrowth. J Neural Eng 10, 056022 (2013).
31. Le, X. L. et al. Fluorescent diamond nanoparticle as a probe of intracellular traffic in primary neurons in culture. Colloidal Nanocrystals for Biomedical Applications VII Book Series: Proc of SPIE 8232, 823203 (2012).
32. Liu, K. K., Cheng, C. L., Chang, C. C. & Chao, J. I. Biocompatible and detectable carboxylated nanodiamond on human cell. Nanotechnology 18, 325102 (2007).
33. Liu, K. K., Wang, C. C., Cheng, C. L. & Chao, J. I. Endocytic carboxylated nanodiamond for the labeling and tracking of cell division and differentiation in cancer and stem cells. Biomaterials 30, 4249-59 (2009).
34. Lien, Z. Y. et al. Cancer cell labeling and tracking using fluorescent and magnetic nanodiamond. Biomaterials 33, 6172-85 (2012).
35. Schrand, A. M., Lin, J. B., Hens, S. C. & Hussain, S. M. Temporal and mechanistic tracking of cellular uptake dynamics with novel surface fluorophore-bound nanodiamonds. Nanoscale 3, 435-45 (2011).
36. Vaijayanthimala, V., Tzeng, Y. K., Chang, H. C. &Li, C. L. The biocompatibility of fluorescent nanodiamonds and their mechanism of cellular uptake. Nanotechnology 20, 425103 (2009).
37. Paget, V. S. et al. Carboxylated nanodiamonds are neither cytotoxic nor genotoxic on liver, kidney, intestine and lung human cell lines. Nanotoxicology DOI:10. 3109/17435390. 2013. 855828 (2013).
38. Vaijayanthimala, V. et al. The long-term stability and biocompatibility of fluorescent nanodiamond as an in vivo contrast agent. Biomaterials 33, 7794-802 (2012).
39. Chow, E. K. et al. Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment. Sci Transl Med 3, 73ra21 (2011).
40. Blaber, S. P. et al. Effect of labeling with iron oxide particles or nanodiamonds on the functionality of adipose-derived mesenchymal stem cells. PLoS One 8, e52997 (2013).
41. Wu, T. J. et al. Tracking the engraftment and regenerative capabilities of transplanted lung stem cells using fluorescent nanodiamonds. NatNanotechnol 8, 682-689 (2013).
42. Power, C. & Rasko, J. E. J. Promises and challenges of stem cell research for regenerative medicine. Ann Intern Med 155, 706-713 (2011).
43. Jonesvilleneuve, E. M. V., Rudnicki, M. A., Harris, J. F. & McBurney, M. W. Retinoic acid-induced neural differentiation of embryonal carcinoma cells. Mol Cell Biol 3, 2271-2279 (1983). (Pubitemid 14224710)
44. Duester, G. Retinoic acid synthesis and signaling during early organogenesis. Cell 134, 921-931 (2008).
45. Memberg, S. P. & Hall, A. K. Dividing neuron precursors express neuron-specific tubulin. J Neurobiol 27, 26-43 (1995).
46. Maia, J. et al. Controlling the neuronal differentiation of stem cells by the intracellular delivery of retinoic acid-loaded nanoparticles. ACS Nano 5, 97-106 (2011).
47. Santos, T. et al. Polymeric nanoparticles to control the differentiation of neural stem cells in the subventricular one of the brain. ACS Nano 6, 10463-10474 (2012).
48. Yagi, H., Yanagisawa, M., Kato, K. & Yu, R. K. Lysosome-associated membrane protein 1 is a major SSEA-1-carrier protein in mouse neural stem cells. Glycobiology 20, 976-981 (2010).
49. Chu, Z. et al. Unambiguous observation of shape effects on cellular fate of nanoparticles. Sci Rep 4, 4495 (2014).